Owens & Minor (OMI) Expected to Announce Quarterly Earnings on Tuesday

Owens & Minor (NYSE:OMI) is anticipated to announce its earnings results before the market opens on Tuesday, February 18th. Analysts expect the company to announce earnings of $0.54 per share and revenue of $2.73 billion for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Owens & Minor Stock Down 3.8 %

Shares of NYSE:OMI opened at $7.45 on Friday. The company has a 50 day moving average of $12.80 and a two-hundred day moving average of $13.84. Owens & Minor has a 52-week low of $7.41 and a 52-week high of $28.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The company has a market capitalization of $574.08 million, a price-to-earnings ratio of -11.45, a price-to-earnings-growth ratio of 0.25 and a beta of 0.48.

Wall Street Analyst Weigh In

Several research firms recently weighed in on OMI. Barclays reduced their target price on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating for the company in a report on Tuesday, November 5th. Robert W. Baird reduced their target price on Owens & Minor from $15.00 to $14.00 and set a “neutral” rating for the company in a report on Tuesday, February 4th. UBS Group dropped their price target on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday. Finally, Citigroup dropped their price target on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, Owens & Minor presently has a consensus rating of “Hold” and a consensus target price of $16.79.

Insider Activity

In other news, CFO Jonathan A. Leon sold 5,282 shares of the business’s stock in a transaction that occurred on Thursday, November 21st. The stock was sold at an average price of $11.82, for a total transaction of $62,433.24. Following the sale, the chief financial officer now directly owns 130,822 shares in the company, valued at approximately $1,546,316.04. The trade was a 3.88 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 3.59% of the stock is currently owned by company insiders.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.